Crossject
Develops emergency medications delivered via a needle-free auto-injector platform.
ALCJ | PA
Overview
Corporate Details
- ISIN(s):
- FR0004178614 (+6 more)
- LEI:
- 969500W1VTFNL2D85A65
- Country:
- France
- Address:
- 6 Rue Pauline Kergomard, 21000 dijon
- Website:
- https://www.crossject.com/en
- Sector:
- Manufacturing
Description
Crossject is a specialty pharmaceutical company focused on developing and commercializing medications for life-threatening emergency situations. The company's core technology is ZENEO®, a proprietary, pre-filled, single-use needle-free auto-injector. This platform is designed to enable patients or untrained caregivers to rapidly, safely, and reliably administer emergency treatments. Crossject's product pipeline targets critical conditions such as epileptic seizures, acute adrenal crisis, and severe allergic reactions (anaphylaxis), aiming to improve patient outcomes by simplifying drug delivery in urgent scenarios.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-07-13 19:26 |
CROSSJECT répond à l'ensemble des questions posées par les actionnaires et inve…
|
French | 121.7 KB | ||
| 2021-06-25 17:56 |
Crossject : Crossject à l'écoute de ses actionnaires et des investisseurs
|
French | 120.2 KB | ||
| 2021-06-22 17:57 |
Crossject : Information relative au nombre total de droits de vote et d'actions…
|
French | 126.1 KB | ||
| 2021-06-16 07:30 |
CROSSJECT : Accord de licence aux États-Unis et au Canada avec Eton Pharmaceuti…
|
French | 104.4 KB | ||
| 2021-06-16 07:30 |
CROSSJECT : US & Canada licensing agreement with Eton Pharmaceuticals for Cro…
|
English | 103.0 KB | ||
| 2021-05-31 18:02 |
Crossject : Information relative au nombre total de droits de vote et d'actions…
|
English | 126.2 KB | ||
| 2021-05-20 17:46 |
CROSSJECT : Tenue à huis clos de l'Assemblée Générale du 25 juin 2021
|
French | 130.7 KB | ||
| 2021-03-29 19:12 |
CROSSJECT : Résultats annuels 2020 et point d'activité
|
French | 302.1 KB | ||
| 2021-03-03 18:20 |
Crossject: Information relative au nombre de droits de vote et d'actions compos…
|
French | 125.8 KB | ||
| 2021-02-19 13:12 |
Crossject : Crossject, lauréate du plan de relance, obtient une aide de 1,5 M€
|
French | 112.0 KB | ||
| 2021-02-18 13:43 |
Visite par Monsieur Bruno Le Maire de Crossject sur le site de Gray
|
French | 82.7 KB | ||
| 2020-12-18 18:00 |
Crossject : Information relative au nombre total de droits de vote et d'actions…
|
French | 95.6 KB | ||
| 2020-12-14 18:44 |
CROSSJECT : CROSSJECT lève avec succès 12M€ de financement
|
French | 87.3 KB | ||
| 2020-11-18 17:51 |
Crossject : Information relative au nombre total de droits de vote et d'actions…
|
French | 201.9 KB | ||
| 2020-10-12 18:17 |
Crossject : Information relative au nombre total de droits de vote et d'actions…
|
French | 202.0 KB |
Automate Your Workflow. Get a real-time feed of all Crossject filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Crossject
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Crossject via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-06-24 | N/A | Other | Buy | 20,000 | N/A |
| 2024-06-14 | N/A | Other | Other | 10,979 | 20,289.19 EUR |
| 2024-06-06 | N/A | Other | Other | 1,058,617 | 1,956,324.22 EUR |
| 2024-06-06 | N/A | Other | Other | 16,106 | 29,763.89 EUR |
| 2024-06-06 | N/A | Other | Other | 10,275 | 18,988.20 EUR |
| 2024-06-06 | N/A | Other | Other | 10,074 | 18,616.75 EUR |
| 2024-06-06 | N/A | Other | Buy | 5,536 | 10,230.53 EUR |
| 2023-03-06 | N/A | Other | Other | 22,859 | 75,434.70 EUR |
Peer Companies
